What Does Nemifitide diTFA Mean?
MI-CP151 was a period 1b randomised, double-blind, placebo managed, dose-escalation, multicentre examine To judge many intravenous doses of sifalimumab, in adult individuals with dermatomyositis or polymyositis (NCT00533091). Major demo targets ended up To judge the protection and tolerability of sifalimumab in dermatomyositis or polymyositis suffe